Arkolith/Insider Trading/TNXP/Form 4

Sullivan Gregory M

Chief Medical OfficerTonix Pharmaceuticals Holding Corp. (TNXP) · full profile →Form 4 · filed Feb 27, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2025Other(J)0$1.47$00

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 25, 2025Grant(A)29K—$029K
Feb 25, 2025Grant(A)29K—$029K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001839882-25-011955) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML